Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology • Internal Medicine • Rheumatology • Thrombosis • Hematology • Pediatric Hematology • Benign Hematology • General Rheumatology • Hemostasis/Thrombosis
In patients who develop a VTE, what conditions do you consider as persistent, provoking risk factors, and at what point are they controlled enough to stop anticoagulation?
I.e., what constitutes well-controlled cancer, IBD, nephrotic syndrome, etc. What other diseases do you put in this category (obesity, autoimmune disease)?
Answer from: at Academic Institution
Not a lot of controlled trials that address each situation so we rely on expert consensus and judgement, and more importantly, balancing the risk of hemorrhage vs thrombosis. ASH guidelines define chronic persistent risk factors as 1) Active cancer (e.g., ongoing chemotherapy; recurrent or progressi...
Sign in or Register to read more